Search by Drug Name or NDC
NDC 61919-0751-20 ZOLPIDEM TARTRATE 5 mg/1 Details
ZOLPIDEM TARTRATE 5 mg/1
ZOLPIDEM TARTRATE is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Direct_Rx. The primary component is ZOLPIDEM TARTRATE.
MedlinePlus Drug Summary
Zolpidem is used to treat insomnia (difficulty falling asleep or staying asleep). Zolpidem belongs to a class of medications called sedative-hypnotics. It works by slowing activity in the brain to allow sleep.
Related Packages: 61919-0751-20Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Zolpidem
Product Information
| NDC | 61919-0751 |
|---|---|
| Product ID | 61919-751_0e993cb8-eccb-240d-e063-6394a90a98e4 |
| Associated GPIs | 60204080100310 |
| GCN Sequence Number | 019187 |
| GCN Sequence Number Description | zolpidem tartrate TABLET 5 MG ORAL |
| HIC3 | H2E |
| HIC3 Description | SEDATIVE-HYPNOTICS,NON-BARBITURATE |
| GCN | 00870 |
| HICL Sequence Number | 007842 |
| HICL Sequence Number Description | ZOLPIDEM TARTRATE |
| Brand/Generic | Generic |
| Proprietary Name | ZOLPIDEM TARTRATE |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | ZOLPIDEM TARTRATE |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 5 |
| Active Ingredient Units | mg/1 |
| Substance Name | ZOLPIDEM TARTRATE |
| Labeler Name | Direct_Rx |
| Pharmaceutical Class | Central Nervous System Depression [PE], GABA A Agonists [MoA], Pyridines [CS], gamma-Aminobutyric Acid-ergic Agonist [EPC] |
| DEA Schedule | CIV |
| Marketing Category | ANDA |
| Application Number | ANDA077903 |
| Listing Certified Through | 2025-12-31 |
Package
NDC 61919-0751-20 (61919075120)
| NDC Package Code | 61919-751-20 |
|---|---|
| Billing NDC | 61919075120 |
| Package | 20 TABLET in 1 BOTTLE (61919-751-20) |
| Marketing Start Date | 2019-08-19 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |